Clinical Trials on Nasopharyngeal Cancinoma (NPC) in Hong Kong
Total 641 results
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsPhilippines, Korea, Republic of, Singapore, Sweden, Malaysia, India, Serbia, Thailand, Croatia, Hong Kong, Poland
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small Cell LungChina, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
-
National Cancer Centre, SingaporeIqvia Pty Ltd; Singapore Clinical Research Institute; Asia-Pacific Hepatocellular...CompletedHepatocellular CarcinomaChina, Korea, Republic of, Taiwan, Australia, Hong Kong, Singapore, New Zealand, Japan, Thailand
-
Singapore General HospitalNational Cancer Centre, Singapore; National Medical Research Council (NMRC)... and other collaboratorsUnknownHepatocellular CarcinomaTaiwan, Korea, Republic of, Malaysia, New Zealand, Philippines, Singapore, China, Thailand, Brunei Darussalam, Indonesia, Mongolia, Myanmar
-
Soon Chun Hyang UniversityUnknownBile Duct Obstruction | Klatskin's TumorKorea, Republic of
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain
-
ImunonCompletedHepatocellular CarcinomaKorea, Republic of, China, Hong Kong, Singapore, Thailand, Malaysia, United States, Canada, Taiwan, Spain, Philippines, Germany, Italy, Vietnam
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
The Catholic University of KoreaJanssen Korea, Ltd., KoreaCompletedEarly Gastric Adenocarcinoma | Adenocarcinoma, TubularKorea, Republic of
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Samyang Biopharmaceuticals CorporationCompleted
-
Eisai Inc.CompletedKIF5B-RET-Positive Adenocarcinoma of the LungUnited States, Hong Kong, Japan, Taiwan, Singapore
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRecurrent Colon Carcinoma | Metastatic Colorectal Carcinoma | Stage IV Colon Cancer AJCC v7 | Stage IVA Colon Cancer AJCC v7 | Stage IVB Colon Cancer AJCC v7 | Refractory Colorectal CarcinomaUnited States
-
Gynecologic Oncology Trial & Investigation ConsortiumJapanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaJapan, United States, Hong Kong, Korea, Republic of, New Zealand, Singapore
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited Kingdom, Taiwan, Brazil, China, India, Korea, Republic of, Hong Kong
-
Pfizer's Upjohn has merged with Mylan to form Viatris...TerminatedAdenomatous Polyposis ColiItaly, United States, Belgium, Spain, Puerto Rico, Sweden, Israel, Czechia, Hong Kong, Hungary, Slovakia, South Africa, Ukraine, United Kingdom
-
Bristol-Myers SquibbCompletedHepatocellular Carcinoma (HCC)France, Korea, Republic of, Taiwan, United States, Singapore, Philippines, Malaysia, Hong Kong
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Canada, Russian Federation, United States, Argentina, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, HepatocellularKorea, Republic of, China, Hong Kong, Malaysia, Taiwan
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
AstraZenecaRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of, Italy, Spain, Vietnam, Germany, France, Japan, United States, Hong Kong, Singapore
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Merck KGaA, Darmstadt, GermanyTerminatedNon-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore, China, Hong Kong
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
Merck Sharp & Dohme LLCCompletedNeoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, New Zealand, Singapore, Taiwan
-
PfizerCompletedCarcinoma, Non-small CellUnited States, Taiwan, Korea, Republic of, Japan, Hong Kong
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
Shanghai EpimAb Biotherapeutics Co., Ltd.CovanceRecruitingNeoplasms | Neoplasm Metastasis | Non-Small-Cell Lung CancerUnited States, China
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Taiwan, Belgium, Israel, Australia, Hong Kong, China, Czech Republic
-
US Department of Veterans AffairsOrtho DermatologicsCompletedCarcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin NeoplasmsUnited States
-
Novartis PharmaceuticalsCompleted
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
AstraZenecaCompletedNon Small Cell Lung CancerVietnam, Philippines, China, Hong Kong, Taiwan, Thailand, India
-
SC Liver Research Consortium, LLCBayerTerminated
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
MacroGenicsCompletedCervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid TumorsHong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine